Full Text:   <2409>

Summary:  <1776>

Suppl. Mater.: 

CLC number: 

On-line Access: 2017-01-03

Received: 2016-05-16

Revision Accepted: 2016-09-12

Crosschecked: 2016-12-16

Cited: 0

Clicked: 4148

Citations:  Bibtex RefMan EndNote GB/T7714


Li-na Han


-   Go to

Article info.
Open peer comments

Journal of Zhejiang University SCIENCE B 2017 Vol.18 No.1 P.70-75


Successful treatment of accessory breast cancer with endocrine therapy

Author(s):  Chun-xi Wang, Shu-li Guo, Li-na Han

Affiliation(s):  Department of General Surgery, Hainan Branch of Chinese PLA General Hospital, Beijing 100853, China; more

Corresponding email(s):   hanlina3399111@sina.com

Key Words:  Accessory breast cancer, Endocrine therapy

Chun-xi Wang, Shu-li Guo, Li-na Han. Successful treatment of accessory breast cancer with endocrine therapy[J]. Journal of Zhejiang University Science B, 2017, 18(1): 70-75.

@article{title="Successful treatment of accessory breast cancer with endocrine therapy",
author="Chun-xi Wang, Shu-li Guo, Li-na Han",
journal="Journal of Zhejiang University Science B",
publisher="Zhejiang University Press & Springer",

%0 Journal Article
%T Successful treatment of accessory breast cancer with endocrine therapy
%A Chun-xi Wang
%A Shu-li Guo
%A Li-na Han
%J Journal of Zhejiang University SCIENCE B
%V 18
%N 1
%P 70-75
%@ 1673-1581
%D 2017
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B1600220

T1 - Successful treatment of accessory breast cancer with endocrine therapy
A1 - Chun-xi Wang
A1 - Shu-li Guo
A1 - Li-na Han
J0 - Journal of Zhejiang University Science B
VL - 18
IS - 1
SP - 70
EP - 75
%@ 1673-1581
Y1 - 2017
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B1600220

accessory breast cancers in males are extremely rare, and only a few cases have been reported in the literature. In this paper, an 87-year-old male patient was diagnosed with an accessory breast cancer by means of computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography-computed tomography (PET-CT), and immunohistochemistry based on needle biopsy, and has undergone successful resection and postoperative adjuvant endocrine therapy. He was the oldest male patient with an accessory breast cancer reported in the Chinese Hospital Knowledge Database and PubMed literature from 1975 to 2015.



Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article


[1]Bi, L., Li, J., Shi, Z., et al., 2015. Male accessory breast cancer successfully treated with endocrine therapy: a case report. Oncol. Lett., 10(4):2495-2498.

[2]Burger, A.E., Pain, S.J., Peley, G., 2013. Treatment of recurrent breast cancer following breast conserving surgery. Breast J., 19(3):310-318.

[3]Camisa, C., 1980. Accessory breast on the posterior thigh of a man. J. Am. Acad. Dermatol., 3(5):467-469.

[4]Gao, Y.G., Zhang, S.H., Wang, Y., 2014. A case of accessory mammary cancer in a male patient and a literature review. Eur. J. Gynaecol. Oncol., 35(4):452-455.

[5]Giordano, S.H., Cohen, D.S., Buzdar, A.U., et al., 2004. Breast carcinoma in men: a population-based study. Cancer, 101(1):51-57.

[6]Gou, Z.Y., 1987. Male accessory breast cancer: a case report. Chongqing Med., 16(2):63 (in Chinese).

[7]Gutermuth, J., Audring, H., Voit, C., et al., 2006. Primary carcinoma of ectopic axillary breast tissue. J. Eur. Acad. Dermatol. Venereol., 20(2):217-221.

[8]Hao, J.Y., Yang, C.C., Liu, F.F., et al., 2012. Accessory breast cancer occurring concurrently with bilateral primary invasive breast carcinomas: a report of two cases and literature review. Cancer Biol. Med., 9(3):197-201.

[9]Jiang, X., 2015. Macrophage-produced IL-10 limits the chemotherapy efficacy in breast cancer. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 16(1):44-45.

[10]Lin, Y., Wang, Y., 2012. Case report of a male primary breast carcinoma of axillary accessory mammary gland. Clin. Breast Cancer, 12(2):142-144.

[11]Litière, S., Werutsky, G., Fentiman, I.S., et al., 2012. Breast conserving therapy versus mastectomy for stage I‒II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol., 13(4):412-419.

[12]Liu, H.Y., Wang, Y., 2014. Clinical pathological characteristics of male accessory breast cancer: analysis of 1 cases and literature review. Chin. J. Clin. Res., 27(1):83-84 (in Chinese).

[13]Ribeiro, G., Swindell, R., 1992. Adjuvant Tamoxifen for male breast cancer (MBC). Br. J. Cancer, 65(2):252-254.

[14]Takeyama, H., Takahashi, H., Tabei, I., et al., 2010. Malignant neoplasm in the axilla of a male: suspected primary carcinoma of an accessory mammary gland. Breast Cancer, 17(2):151-154.

[15]Yamamura, J., Masuda, N., Kodama, Y., et al., 2012. Male breast cancer originating in an accessory mammary gland in the axilla: a case report. Case Rep. Med., 2012:286210.

[16]Yoshida, Y., Sakakibara, A., Watanabe, T., et al., 2012. Extraordinarily large protruding accessory breast cancer in a man. J. Am. Acad. Dermatol., 67(5):e230-e231.

[17]Zhang, J., Liu, Y., 2008. HER2 over-expression and response to different chemotherapy regimens in breast cancer. J. Zhejiang Univ.-Sci. B, 9(1):5-9.

[18]List of electronic supplementary materials

[19]Fig. S1 Delineation of surgical resection before operation

[20]Fig. S2 Magnetic resonance imaging (MRI) findings of the breast

[21]Fig. S3 Cut-down accessory breast cancer

Open peer comments: Debate/Discuss/Question/Opinion


Please provide your name, email address and a comment

Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn
Copyright © 2000 - 2024 Journal of Zhejiang University-SCIENCE